These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 25487009)

  • 1. Natural products as exquisitely potent cytotoxic payloads for antibody- drug conjugates.
    Gromek SM; Balunas MJ
    Curr Top Med Chem; 2015; 14(24):2822-34. PubMed ID: 25487009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive review on the elaboration of payloads derived from natural products for antibody-drug conjugates.
    Lu N; Wu J; Tian M; Zhang S; Li Z; Shi L
    Eur J Med Chem; 2024 Mar; 268():116233. PubMed ID: 38408390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The next generation of antibody drug conjugates.
    Mack F; Ritchie M; Sapra P
    Semin Oncol; 2014 Oct; 41(5):637-52. PubMed ID: 25440608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates.
    Yamada K; Ito Y
    Chembiochem; 2019 Nov; 20(21):2729-2737. PubMed ID: 30973187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-Drug Conjugates Containing Payloads from Marine Origin.
    Cheng-Sánchez I; Moya-Utrera F; Porras-Alcalá C; López-Romero JM; Sarabia F
    Mar Drugs; 2022 Jul; 20(8):. PubMed ID: 36005497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-Specific Conjugation of Thiol-Reactive Cytotoxic Agents to Nonnative Cysteines of Engineered Monoclonal Antibodies.
    Dickgiesser S; Kellner R; Kolmar H; Rasche N
    Methods Mol Biol; 2019; 2033():1-14. PubMed ID: 31332743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total Synthesis in Search of Potent Antibody-Drug Conjugate Payloads. From the Fundamentals to the Translational.
    Nicolaou KC; Rigol S
    Acc Chem Res; 2019 Jan; 52(1):127-139. PubMed ID: 30575399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-drug conjugates: an emerging modality for the treatment of cancer.
    Leal M; Sapra P; Hurvitz SA; Senter P; Wahl A; Schutten M; Shah DK; Haddish-Berhane N; Kabbarah O
    Ann N Y Acad Sci; 2014 Aug; 1321():41-54. PubMed ID: 25123209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies.
    Ducry L; Stump B
    Bioconjug Chem; 2010 Jan; 21(1):5-13. PubMed ID: 19769391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review.
    Rossi C; Chrétien ML; Casasnovas RO
    Target Oncol; 2018 Jun; 13(3):287-308. PubMed ID: 29556925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluation of cysteine and site specific conjugated herceptin antibody-drug conjugates.
    Jackson D; Atkinson J; Guevara CI; Zhang C; Kery V; Moon SJ; Virata C; Yang P; Lowe C; Pinkstaff J; Cho H; Knudsen N; Manibusan A; Tian F; Sun Y; Lu Y; Sellers A; Jia XC; Joseph I; Anand B; Morrison K; Pereira DS; Stover D
    PLoS One; 2014; 9(1):e83865. PubMed ID: 24454709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Design of next generation antibody drug conjugates].
    Zhu GD; Fu YX
    Yao Xue Xue Bao; 2013 Jul; 48(7):1053-70. PubMed ID: 24133971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Product Splicing Inhibitors: A New Class of Antibody-Drug Conjugate (ADC) Payloads.
    Puthenveetil S; Loganzo F; He H; Dirico K; Green M; Teske J; Musto S; Clark T; Rago B; Koehn F; Veneziale R; Falahaptisheh H; Han X; Barletta F; Lucas J; Subramanyam C; O'Donnell CJ; Tumey LN; Sapra P; Gerber HP; Ma D; Graziani EI
    Bioconjug Chem; 2016 Aug; 27(8):1880-8. PubMed ID: 27412791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody drug conjugates: lessons from 20 years of clinical experience.
    Tolcher AW
    Ann Oncol; 2016 Dec; 27(12):2168-2172. PubMed ID: 27733376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The target invites a foe: antibody-drug conjugates in gynecologic oncology.
    Campos MP; Konecny GE
    Curr Opin Obstet Gynecol; 2018 Feb; 30(1):44-50. PubMed ID: 29227302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-drug conjugates of 7-ethyl-10-hydroxycamptothecin: Sacituzumab govitecan and labetuzumab govitecan.
    Dong W; Shi J; Yuan T; Qi B; Yu J; Dai J; He L
    Eur J Med Chem; 2019 Apr; 167():583-593. PubMed ID: 30822636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics.
    Gerber HP; Koehn FE; Abraham RT
    Nat Prod Rep; 2013 May; 30(5):625-39. PubMed ID: 23525375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-Drug Conjugates-A Tutorial Review.
    Baah S; Laws M; Rahman KM
    Molecules; 2021 May; 26(10):. PubMed ID: 34063364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computationally designed antibody-drug conjugates self-assembled via affinity ligands.
    Gupta N; Ansari A; Dhoke GV; Chilamari M; Sivaccumar J; Kumari S; Chatterjee S; Goyal R; Dutta PK; Samarla M; Mukherjee M; Sarkar A; Mandal SK; Rai V; Biswas G; Sengupta A; Roy S; Roy M; Sengupta S
    Nat Biomed Eng; 2019 Nov; 3(11):917-929. PubMed ID: 31686001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors.
    Charmsaz S; Scott AM; Boyd AW
    Exp Hematol; 2017 Oct; 54():31-39. PubMed ID: 28751189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.